VD

Vamil Divan Guggenheim Latest Price Targets & Analyst Ratings

Stock Price Price Target Upside
Downside
Rating Date
ABBV icon
1
AbbVie
ABBV
$375B
$212.51 $227
7%
upside
Buy 1 month ago
JNJ icon
2
Johnson & Johnson
JNJ
$430B
$178.38 $167
6%
downside
Neutral 1 month ago
PROK icon
3
ProKidney
PROK
$304M
$2.25 $7
211%
upside
Buy 1 month ago
JBIO
4
Jade Biosciences, Inc. Common Stock
JBIO
$253M
$7.76 $14
80%
upside
Buy 2 months ago
SVRA icon
5
Savara
SVRA
$641M
$3.71 $8
116%
upside
Buy 3 months ago
AMGN icon
6
Amgen
AMGN
$153B
$283.55 $288
2%
upside
Neutral 3 months ago
ANIP icon
7
ANI Pharmaceuticals
ANIP
$2.07B
$95.37 $86
10%
downside
Buy 3 months ago
VALN
8
Valneva
VALN
$742M
$8.64 $14
62%
upside
Buy 4 months ago
MRK icon
9
Merck
MRK
$212B
$84.71 $115
36%
upside
Buy 4 months ago
TVTX icon
10
Travere Therapeutics
TVTX
$1.93B
$21.66 $47
117%
upside
Buy 4 months ago
ABSI icon
11
Absci
ABSI
$368M
$2.46 $10
307%
upside
Buy 5 months ago
VERA icon
12
Vera Therapeutics
VERA
$1.55B
$24.21 $61
152%
upside
Buy 6 months ago
INSM icon
13
Insmed
INSM
$30.7B
$145.12 $101
30%
downside
Buy 6 months ago
ACAD icon
14
Acadia Pharmaceuticals
ACAD
$4.26B
$25.26 $19
25%
downside
Neutral 3 years ago
NBIX icon
15
Neurocrine Biosciences
NBIX
$14.3B
$144.13 $98
32%
downside
Neutral 3 years ago
ALKS icon
16
Alkermes
ALKS
$4.94B
$29.94 $34
14%
upside
Buy 3 years ago
AXSM icon
17
Axsome Therapeutics
AXSM
$6.25B
$125.20 $49
61%
downside
Buy 3 years ago
LLY icon
18
Eli Lilly
LLY
$652B
$726.81 $356
51%
downside
Buy 3 years ago
XERS icon
19
Xeris Biopharma Holdings
XERS
$1.27B
$7.87 $6
24%
downside
Buy 3 years ago
BHVN icon
20
Biohaven
BHVN
$1.68B
$15.86 $154
871%
upside
Buy 3 years ago
ABBV icon
21
AbbVie
ABBV
$375B
$212.51 $166
22%
downside
Buy 3 years ago
PFE icon
22
Pfizer
PFE
$142B
$24.89 $56
125%
upside
Neutral 3 years ago
EOLS icon
23
Evolus
EOLS
$496M
$7.67 $15
96%
upside
Buy 4 years ago